SCHEMBL15427754

SCHEMBL15427754

COc1nc(C(=O)OC(C)(C)C)c(OCc2ccccc2)c(=O)[nH]1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
USP2 O75604 1/20 0.46
TSHR P16473 1/20 0.46
HSD17B10 Q99714 1/20 0.46
LMNA P02545 3/20 0.43
HPGD P15428 1/20 0.43
LIPG Q9Y5X9 2/20 0.42
KDM4C Q9H3R0 1/20 0.38
RNASEH1 O60930 1/20 0.38
HCAR2 Q8TDS4 1/20 0.38
SRD5A1 P18405 1/20 0.37
SRD5A2 P31213 1/20 0.37
POLB P06746 2/20 0.36
MAPT P10636 1/20 0.36
MMP1 P03956 1/20 0.36
MMP2 P08253 1/20 0.36
MMP9 P14780 1/20 0.36
MMP12 P39900 1/20 0.36
MMP13 P45452 1/20 0.36
PTPN1 P18031 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15320780 0.86 ALDH1A1 (0.48) ALDH1A1USP2TSHRHSD17B10LMNA
SCHEMBL6367799 0.82 USP2 (0.41) ALDH1A1USP2TSHRHSD17B10LMNA
SCHEMBL1668871 0.80 USP2 (0.53) ALDH1A1USP2TSHRHSD17B10LMNA
SCHEMBL2551523 0.79 POLB (0.47) ALDH1A1USP2TSHRHSD17B10POLB
SCHEMBL15863079 0.78 USP2 (0.38) ALDH1A1USP2TSHRHSD17B10LMNA
SCHEMBL15863385 0.78 RNASEH1 (0.42) ALDH1A1USP2TSHRHSD17B10LMNA
SCHEMBL15863094 0.76 ALDH1A1 (0.37) ALDH1A1USP2TSHRHSD17B10LMNA
SCHEMBL15862692 0.75 RNASEH1 (0.40) ALDH1A1USP2TSHRHSD17B10LMNA
SCHEMBL15862918 0.75 RNASEH1 (0.36) ALDH1A1USP2TSHRHSD17B10LMNA
SCHEMBL15862944 0.74 RNASEH1 (0.39) ALDH1A1USP2TSHRHSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2870152-B1 AMIDE OR UREA SUBSTITUTED BENZOTHIAZOLE DERIVATIVES AS INHIBITORS OF ENDOTHELIAL LIPASE BRISTOL MYERS SQUIBB CO (US) 2016-09-28 EP disclosed
EP-2870152-B1 AMIDE OR UREA SUBSTITUTED BENZOTHIAZOLE DERIVATIVES AS INHIBITORS OF ENDOTHELIAL LIPASE BRISTOL MYERS SQUIBB CO (US) 2016-09-28 EP disclosed
US-9169240-B2 Ketone linked benzothiazole inhibitors of endothelial lipase BRISTOL-MYERS SQUIBB COMPANY (US) 2015-10-27 US disclosed
US-9139578-B2 Amide or urea containing benzothiazole inhibitors of endothelial lipase BRISTOL-MYERS SQUIBB COMPANY (US) 2015-09-22 US disclosed
US-9139578-B2 Amide or urea containing benzothiazole inhibitors of endothelial lipase BRISTOL-MYERS SQUIBB COMPANY (US) 2015-09-22 US disclosed
US-9139578-B2 Amide or urea containing benzothiazole inhibitors of endothelial lipase BRISTOL-MYERS SQUIBB COMPANY (US) 2015-09-22 US disclosed
US-20150239879-A1 KETONE LINKED BENZOTHIAZOLE INHIBITORS OF ENDOTHELIAL LIPASE BRISTOL-MYERS SQUIBB COMPANY 2015-08-27 US disclosed
US-20150158856-A1 AMIDE OR UREA CONTAINING BENZOTHIAZOLE INHIBITORS OF ENDOTHELIAL LIPASE BRISTOL-MYERS SQUIBB COMPANY 2015-06-11 US disclosed
US-20150158856-A1 AMIDE OR UREA CONTAINING BENZOTHIAZOLE INHIBITORS OF ENDOTHELIAL LIPASE BRISTOL-MYERS SQUIBB COMPANY 2015-06-11 US disclosed
US-20150158856-A1 AMIDE OR UREA CONTAINING BENZOTHIAZOLE INHIBITORS OF ENDOTHELIAL LIPASE BRISTOL-MYERS SQUIBB COMPANY 2015-06-11 US disclosed
US-8680090-B2 Sulfonyl containing benzothiazole inhibitors of endothelial lipase BRISTOL-MYERS SQUIBB COMPANY (US) 2014-03-25 US disclosed
WO-2014011461-A1 AMIDE OR UREA SUBSTITUTED BENZOTHIAZOLE DERIVATIVES AS INHIBITORS OF ENDOTHELIAL LIPASE BRISTOL-MYERS SQUIBB COMPANY (US) 2014-01-16 WO disclosed
US-20140011799-A1 SULFONYL CONTAINING BENZOTHIAZOLE INHIBITORS OF ENDOTHELIAL LIPASE BRISTOL-MYERS SQUIBB COMPANY 2014-01-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150158856-A1 AMIDE OR UREA CONTAINING BENZOTHIAZOLE INHIBITORS OF ENDOTHELIAL LIPASE LIPG, LIPE, CEL ALDH1A1 593/4885USP2 97/4885TSHR 3855/4885
US-20140011799-A1 SULFONYL CONTAINING BENZOTHIAZOLE INHIBITORS OF ENDOTHELIAL LIPASE LIPG, LPL, LIPE ALDH1A1 342/4885USP2 801/4885TSHR 3677/4885
US-20150239879-A1 KETONE LINKED BENZOTHIAZOLE INHIBITORS OF ENDOTHELIAL LIPASE LIPG, LPL, LIPE ALDH1A1 174/4885USP2 932/4885TSHR 3921/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.